Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» COM701
COM701
Compugen COM701 in dual/triple combo shows promise in ovarian cancer patients in trial
Seeking Alpha
Tue, 12/6/22 - 10:31 am
CompuGen
COM701
Bristol Myers Squibb
Opdivo
ovarian cancer
platinum-resistant ovarian cancer
Can This Biotech Shed New Light on Cancer Immunotherapies?
Motley Fool
Mon, 05/4/20 - 10:29 pm
cancer immunotherapy
CompuGen
COM701
Bristol-Myers to invest in Compugen, collaborate in clinical trials
Yahoo/Reuters
Thu, 10/11/18 - 09:43 am
Bristol-Myers Squibb
CompuGen
clinical trials
solid tumors
COM701
Opdivo